STING1 and neoplasm: A sustained interferon-stimulated gene (ISG) program can promote tumor-intrinsic survival pathways, including enhanced DNA damage response and metabolic reprogramming, which together attenuate immunogenic cell death and contribute to reduced responsiveness to therapy.